Medicinal Genomics will continue to support methods validated on the AriaMx instrument indefinitely and there will be no change to Agilent's coverage of the hardware or software until 2031.
Medicinal Genomics (MGC) is a Value Added Reseller of the Agilent AriaMx qPCR system and Agilent Bravo liquid handling platform. We partner with the Agilent Genomics and Analytical Sales teams to support cannabis laboratories and we will continue to do so indefinitely.
Agilent distributed a notice alerting customers of this change on December 5th, 2023. Highlights of that alert and key details are as follows:
- Agilent Technologies plans to discontinue sales of the AriaMx and AriaDx qPCR systems and
software at the end of 2024. - The AriaMx/Dx instruments and software (instrument controller and analysis software) will carry seven years of guaranteed support after 2024 (Fully supported through 2031).
- Parts and service contracts will still be available during this period. After EGS, support and parts will be available on a best-effort basis for up to three years (Through 2034).
- The optical modules are consumable products and will continue to be available.
This notice from Agilent does not impact MGC's consumable products whatsoever. MGC will continue to support methods validated on the AriaMx instrument and will continue to sell the AriaMx until the end of 2024.
There will be no change to Agilent's sales and support of the Bravo liquid handling system.
Please contact sales@medicinalgenomics.com for any questions